BR9712468A - Método para aumentar o número de células pilosas do ouvido interno de mamìferos, composição de proliferação das células de suporte do ouvido interno de mamìferos, método para o tratamento de um distúrbio relacionado com as células pilosas do ouvido interno em um mamìfero kit e sou de igf-1 - Google Patents

Método para aumentar o número de células pilosas do ouvido interno de mamìferos, composição de proliferação das células de suporte do ouvido interno de mamìferos, método para o tratamento de um distúrbio relacionado com as células pilosas do ouvido interno em um mamìfero kit e sou de igf-1

Info

Publication number
BR9712468A
BR9712468A BR9712468-0A BR9712468A BR9712468A BR 9712468 A BR9712468 A BR 9712468A BR 9712468 A BR9712468 A BR 9712468A BR 9712468 A BR9712468 A BR 9712468A
Authority
BR
Brazil
Prior art keywords
inner ear
treatment
mammals
cells
hair cells
Prior art date
Application number
BR9712468-0A
Other languages
English (en)
Inventor
Wei-Qiang Gao
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of BR9712468A publication Critical patent/BR9712468A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

<B>"MéTODO PARA AUMENTAR O NúMERO DE CéLULAS PILOSAS DO OUVIDO INTERNO DE MAMìFEROS, COMPOSIçãO PARA USO NA PROMOçãO DE PROLIFERAçãO DAS CéLULAS DE SUPORTE DO OUVIDO INTERNO DE MAMìFEROS, MéTODO PARA O TRATAMENTO DE UM DISTúRBIO RELACIONADO COM AS CéLULAS PILOSAS DO OUVIDO INTERNO EM UM MAMìFERO, KIT E USO DE IGF-1"<D>. A presente invenção se refere a composições, métodos e dispositivos para a indução ou aumento do crescimento, proliferação, regeneração do tecido do ouvido interno, em particular as células pilosas do ouvido interno. Além disso, a presente invenção se refere a composições e métodos para o tratamento profiláctico ou terapêutico de um mamífero afetado com um distúrbio ou condição do ouvido interno, em particular para diminuições da audição envolvendo o dano, perda ou degeneração das células pilosas, mediante a administração de uma quantidade aceitável do ponto de vista terapêutico de IGF-1 ou FGF-2, ou seus agonistas, isolados ou em combinação.
BR9712468-0A 1996-11-01 1997-10-28 Método para aumentar o número de células pilosas do ouvido interno de mamìferos, composição de proliferação das células de suporte do ouvido interno de mamìferos, método para o tratamento de um distúrbio relacionado com as células pilosas do ouvido interno em um mamìfero kit e sou de igf-1 BR9712468A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2953696P 1996-11-01 1996-11-01
US08/743,267 US6593290B1 (en) 1996-11-01 1996-11-04 Treatment of inner ear hair cells
PCT/US1997/019585 WO1998019700A1 (en) 1996-11-01 1997-10-28 Treatment of inner ear hair cells

Publications (1)

Publication Number Publication Date
BR9712468A true BR9712468A (pt) 1999-10-26

Family

ID=26705049

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712468-0A BR9712468A (pt) 1996-11-01 1997-10-28 Método para aumentar o número de células pilosas do ouvido interno de mamìferos, composição de proliferação das células de suporte do ouvido interno de mamìferos, método para o tratamento de um distúrbio relacionado com as células pilosas do ouvido interno em um mamìfero kit e sou de igf-1

Country Status (15)

Country Link
US (1) US6593290B1 (pt)
EP (1) EP0948349B1 (pt)
JP (1) JP4191252B2 (pt)
CN (1) CN1313147C (pt)
AR (1) AR009603A1 (pt)
AT (1) ATE229815T1 (pt)
AU (1) AU724988B2 (pt)
BR (1) BR9712468A (pt)
CA (1) CA2268331C (pt)
DE (1) DE69718053T2 (pt)
DK (1) DK0948349T3 (pt)
ES (1) ES2189002T3 (pt)
IL (2) IL129381A0 (pt)
WO (1) WO1998019700A1 (pt)
ZA (1) ZA979814B (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
AUPP785098A0 (en) * 1998-12-21 1999-01-21 Victor Chang Cardiac Research Institute, The Treatment of heart disease
US6635249B1 (en) * 1999-04-23 2003-10-21 Cenes Pharmaceuticals, Inc. Methods for treating congestive heart failure
US7053200B1 (en) 1999-06-01 2006-05-30 Baylor College Of Medicine Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
ATE490777T1 (de) 1999-06-01 2010-12-15 Baylor College Medicine Zusammensetzungen und verfahren zur therapeutischen anwendung einer mit dem gen atonal assoziierten sequenz
AU4885500A (en) * 1999-07-27 2001-02-01 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
AU2001288219C1 (en) * 2000-07-11 2009-12-03 Sound Pharmaceuticals Incorporated Stimulation of cellular regeneration and differentiation in the inner ear
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
WO2003099320A1 (en) 2002-05-24 2003-12-04 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
EP1547618B1 (en) * 2002-10-02 2010-05-26 AnGes MG, Inc. Drug for auditory dysfunction
RS54160B1 (sr) 2003-03-19 2015-12-31 Biogen Idec Ma Inc. Protein koji se vezuje za nogo receptor
KR101239542B1 (ko) 2004-06-24 2013-03-07 바이오겐 아이덱 엠에이 인코포레이티드 탈수초화를 수반하는 병의 치료
US20070082858A1 (en) * 2004-12-21 2007-04-12 Oregon Health & Science University Methods and compositions for the prevention of toxic side effects of aminoglycoside medications
RS53058B (en) 2005-07-08 2014-04-30 Biogen Idec Ma Inc. SP35 ANTIBODIES AND THEIR APPLICATIONS
US20070213264A1 (en) 2005-12-02 2007-09-13 Mingdong Zhou Neuregulin variants and methods of screening and using thereof
RU2457854C2 (ru) * 2005-12-30 2012-08-10 Цзэньсунь (Шанхай) Сайенс Энд Текнолоджи Лимитед Длительное высвобождение нейрегулина для улучшения сердечной функции
AU2008325107B2 (en) * 2007-11-08 2015-04-23 Biogen Ma Inc. Use of LINGO-4 antagonists in the treatment of conditions involving demyelination
DK2982695T3 (da) 2008-07-09 2019-05-13 Biogen Ma Inc Sammensætninger, der omfatter antistoffer mod lingo eller fragmenter deraf
US8496957B2 (en) 2008-07-21 2013-07-30 Otonomy, Inc Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
US8447409B2 (en) * 2008-10-15 2013-05-21 Cochlear Limited Electroneural interface for a medical implant
US7934558B2 (en) 2009-03-13 2011-05-03 Halliburton Energy Services, Inc. System and method for dynamically adjusting the center of gravity of a perforating apparatus
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions and methods for treating heart failure
NZ702178A (en) 2012-05-14 2017-01-27 Biogen Ma Inc Lingo-2 antagonists for treatment of conditions involving motor neurons
NZ713219A (en) 2013-03-14 2017-04-28 Massachusetts Inst Technology Compositions and methods for epithelial stem cell expansion and culture
KR102493376B1 (ko) 2014-09-03 2023-01-27 더 브리검 앤드 우먼즈 하스피털, 인크. 청력 손실의 치료를 위해 내이 털세포를 생성하기 위한 조성물, 시스템, 및 방법
TWI710635B (zh) 2014-10-09 2020-11-21 美商珍維克公司 編碼人類無調同源物-1(hath1)之腺病毒載體
AU2016205197B2 (en) 2015-01-08 2021-10-21 Biogen Ma Inc. LINGO-1 antagonists and uses for treatment of demyelinating disorders
CN108779437A (zh) 2016-01-08 2018-11-09 麻省理工学院 分化的肠内分泌细胞和胰岛素产生细胞的制备
US11260130B2 (en) 2016-03-02 2022-03-01 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV
US10201540B2 (en) 2016-03-02 2019-02-12 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I
US10213511B2 (en) 2016-03-02 2019-02-26 Frequency Therapeutics, Inc. Thermoreversible compositions for administration of therapeutic agents
WO2017210553A1 (en) * 2016-06-03 2017-12-07 Hough Ear Institute Combination therapies for inner ear sensory hair cell regeneration/replacement
CN106075392B (zh) * 2016-07-18 2020-07-07 滨州医学院 促红细胞生成素衍生物在听力保护上的应用
US11066419B2 (en) 2016-12-30 2021-07-20 Frequency Therapeutics, Inc. 1H-pyrrole-2,5-dione compounds and methods of using same
AU2019321641A1 (en) 2018-08-17 2021-04-15 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by upregulating Jag-1
WO2020037326A1 (en) 2018-08-17 2020-02-20 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by downregulating foxo
CN109182250A (zh) * 2018-09-30 2019-01-11 山东省立医院 一种小鼠耳蜗毛细胞培养方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4263428A (en) 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
US4637402A (en) 1980-04-28 1987-01-20 Adelman Roger A Method for quantitatively measuring a hearing defect
ATE12348T1 (de) 1980-11-10 1985-04-15 Gersonde Klaus Prof Dr Verfahren zur herstellung von lipid-vesikeln durch ultraschallbehandlung, anwendung des verfahrens und vorrichtung zur durchfuehrung des verfahrens.
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
EP0088046B1 (de) 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
DE3218121A1 (de) 1982-05-14 1983-11-17 Leskovar, Peter, Dr.-Ing., 8000 München Arzneimittel zur tumorbehandlung
EP0102324A3 (de) 1982-07-29 1984-11-07 Ciba-Geigy Ag Lipide und Tenside in wässriger Phase
IL71991A (en) 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
JPS607934A (ja) 1983-06-29 1985-01-16 Dai Ichi Seiyaku Co Ltd リポソ−ムの製造方法
ATE59966T1 (de) 1983-09-26 1991-02-15 Ehrenfeld Udo Mittel und erzeugnis fuer die diagnose und therapie von tumoren sowie zur behandlung von schwaechen der zelligen und humoralen immunabwehr.
EP0143949B1 (en) 1983-11-01 1988-10-12 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Pharmaceutical composition containing urokinase
ATE81779T1 (de) 1985-08-22 1992-11-15 Gropep Pty Ltd Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
US5439818A (en) 1985-09-12 1995-08-08 Scios Nova Inc. DNA encoding human recombinant basic fibroblast growth factor
SE8505922D0 (sv) 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering
ES2007309T3 (es) 1987-04-23 1994-11-01 Monsanto Co Secrecion del factor de crecimiento insulinoide 1 en e.coli.
US4892538A (en) 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
US5470828A (en) 1987-12-24 1995-11-28 Gropep Pty. Ltd. Peptide analogs of insulin-like growth factor II
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
US5352589A (en) 1988-09-16 1994-10-04 Farmitalia Carlo Erba S.R.L. Deletion mutant of basic fibroblast growth factor and production thereof
US5464943A (en) 1989-04-26 1995-11-07 Takeda Chemical Industries, Ltd. DNA encoding glycosylated FGF and production thereof
US5364839A (en) * 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
US5187151A (en) 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
DK0585368T3 (da) 1991-04-25 1998-03-16 Univ Brown Res Found Implanterbart biokompatibelt immunisolatorisk vehikel til afgivelse af udvalgte terapeutiske produkter
JPH06500802A (ja) * 1991-06-14 1994-01-27 アムジエン・インコーポレーテツド コラーゲンフィルムによるタンパクのドラッグ・デリバリー
JPH07504160A (ja) * 1991-11-27 1995-05-11 インスティチュート　オブ　モレキュラー　バイオロジー　インク 骨の再生
US5482929A (en) 1991-12-26 1996-01-09 Kaken Pharmaceutical Co., Ltd. Composition of stabilized fibroblast growth factor
JP3243254B2 (ja) 1992-04-04 2002-01-07 メディカル・リサーチ・カウンシル 聴力検査
DK0661990T3 (da) * 1992-08-26 2002-06-17 Celtrix Pharma Fremgangsmåde til systemisk behandling af kataboliske tilstande og systemisk vævsbeskadigelse
US5407913A (en) 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury
DK0802800T3 (da) 1993-08-12 2002-10-07 Neurotech Sa Biokompatible immunoisolatoriske kapsler indeholdende genetisk ændrede celler for levering af biologisk aktive molekyler
US6136785A (en) * 1995-08-08 2000-10-24 University Of Virginia Patent Foundation Protection from loss of sensory hair cells in the inner ear by administration of insulin-like growth factor and platelet derived growth factor

Also Published As

Publication number Publication date
CN1313147C (zh) 2007-05-02
DE69718053D1 (de) 2003-01-30
ES2189002T3 (es) 2003-07-01
AR009603A1 (es) 2000-04-26
ATE229815T1 (de) 2003-01-15
CA2268331A1 (en) 1998-05-14
CN1251531A (zh) 2000-04-26
DK0948349T3 (da) 2003-04-07
IL129381A (en) 2006-07-05
JP4191252B2 (ja) 2008-12-03
AU724988B2 (en) 2000-10-05
CA2268331C (en) 2011-07-26
EP0948349B1 (en) 2002-12-18
WO1998019700A1 (en) 1998-05-14
JP2002514191A (ja) 2002-05-14
DE69718053T2 (de) 2003-09-11
EP0948349A1 (en) 1999-10-13
IL129381A0 (en) 2000-02-17
US6593290B1 (en) 2003-07-15
AU7000698A (en) 1998-05-29
ZA979814B (en) 1999-04-30

Similar Documents

Publication Publication Date Title
BR9712468A (pt) Método para aumentar o número de células pilosas do ouvido interno de mamìferos, composição de proliferação das células de suporte do ouvido interno de mamìferos, método para o tratamento de um distúrbio relacionado com as células pilosas do ouvido interno em um mamìfero kit e sou de igf-1
Sakai et al. Immunolocalization of cytokines and growth factors in subacromial bursa of rotator cuff tear patients
AU6691098A (en) Method and compositions for healing tissue defects and inducing hypervascularityin mammalian tissue
Andreassi et al. A new model of epidermal culture for the surgical treatment of vitiligo
PT1119362E (pt) Metodos de utilizacao de compostos tetraciclina para aumentar a producao de interleucina-10
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
BR9914109A (pt) Composições antibióticas para tratamento dos olhos, ouvidos e nariz
YU186291A (sh) Novi derivati hidroksamske kiseline i n-hidroksikarbamida
AU579595B2 (en) Enzyme-resistant immunomodulatory peptides
PT1066052E (pt) Celulas estaminais mesenquimatosas para a prevencao e tratamento
NO20050550L (no) Vevsbeskyttende cytokiner for beskyttelse, gjennoppbygging og oking av responsive celler, vev og organer
CA2342211A1 (en) Antibiotic compositions for treatment of the eye, ear and nose
HK1030880A1 (en) Matrix protein compositions for wound healing
CA2070685A1 (en) Method for treating painful, inflammatory or allergic disorders
Perez-Marrero et al. Prolongation of response to DMSO by heparin maintenance
Rieck et al. Increased endothelial survival of organ-cultured corneas stored in FGF-2–supplemented serum-free medium
CA2147123A1 (en) Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
PH23722A (en) Opthalmic use of quinolone antibiotics
BR9611571A (pt) Composição farmacêutica estável composição farmacêutica kit para administração de ngf e método de aumento da estabilidade de ngf
Mot et al. Synergistic antibacterial effect of co-administering adipose-derived mesenchymal stromal cells and Ophiophagus hannah L-amino acid oxidase in a mouse model of methicillin-resistant Staphylococcus aureus-infected wounds
Yazdanpanah et al. Emerging approaches for ocular surface regeneration
WO2007055760A3 (en) Protein composition for promoting wound healing and skin regeneration
BR0107544A (pt) Composição de promoção de secreção de bile
HK1030540A1 (en) Synergistic effects of op/bmp morphogens and gdnf/ngf neurotrophic factors op/bmp

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time